MedPath

JENNIFER MITCHELL

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Oxytocin on Approach Bias and Craving

Phase 2
Withdrawn
Conditions
Alcohol Use Disorder
Interventions
Drug: Oxytocin
Drug: Placebo
First Posted Date
2019-03-07
Last Posted Date
2022-06-06
Lead Sponsor
Jennifer Mitchell
Registration Number
NCT03865615
Locations
🇺🇸

University of California, San Francisco, Berkeley, California, United States

Oxytocin Suppresses Substance Use Disorders Associated With Chronic Stress

Phase 2
Completed
Conditions
Alcohol Use Disorder
Anxiety Disorders
Stress Disorders, Post-Traumatic
Substance Use Disorders
Interventions
Drug: Placebo
Drug: Oxytocin
First Posted Date
2016-04-19
Last Posted Date
2020-10-19
Lead Sponsor
Jennifer Mitchell
Target Recruit Count
63
Registration Number
NCT02742532
Locations
🇺🇸

Naval Medical Center San Diego, San Diego, California, United States

Effects of Tolcapone on Decision Making and Alcohol Intake in Alcohol Users

Phase 2
Completed
Conditions
Alcohol Abuse
Impulsive Behavior
Interventions
Drug: Tolcapone
Drug: Placebo
First Posted Date
2016-04-15
Last Posted Date
2020-09-21
Lead Sponsor
Jennifer Mitchell
Target Recruit Count
62
Registration Number
NCT02740582
Locations
🇺🇸

University of California, Berkeley, Berkeley, California, United States

🇺🇸

University of California, San Francisco, San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath